Key facts
- Notable investors include Redhill Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Xiangkang Medical Research
- ·The full record, as it builds
Funding rounds
No funding rounds for Xiangkang Medical Research are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xiangkang Medical Research
Manufacturer of a medical device intended for life science industries. The company offers the CRDMO model, integrates CRO (contract research), CDO (contract development) and CMO (contract manufacturing) services, serving the medical industry with achievement transformation, research and development design, clinical evaluation, global registration and production intelligence.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2015
- Employees
- 39
- Website
- xkbiotec.com/
- Ownership
- Privately Held (backing)
Xiangkang Medical Research doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xiangkang Medical Research shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xiangkang Medical Research in its N-PORT filings yet. We sweep new filings monthly.